1. Chemokines in Prediabetes and Type 2 Diabetes: A Meta-Analysis
   Xiongfeng Pan et al, 2021, Frontiers in Immunology CrossRef
2. Effect and cardiovascular safety of adding rosiglitazone to insulin therapy in type 2 diabetes: A meta‐analysis
   Yu Lu et al, 2015, Journal of Diabetes Investigation CrossRef
3. Potential impact of Paracentrotus lividus extract on diabetic rat models induced by high fat diet/streptozotocin
   Amel M. Soliman, 2016, The Journal of Basic & Applied Zoology CrossRef
4. Peroxisome Proliferator-Activated Receptor Targets for the Treatment of Metabolic Diseases
   Francisco A. Monsalve et al, 2013, Mediators of Inflammation CrossRef
5. Assessment of serum arginase I as a type 2 diabetes mellitus diagnosis biomarker in patients
   SONG WANG et al, 2014, Experimental and Therapeutic Medicine CrossRef
6. Association of Monocyte Chemoattractant Protein‐1 (MCP‐1)‐2518A>G Polymorphism with Susceptibility to Coronary Artery Disease: A Meta‐Analysis
   Xiao‐Yan Bai et al, 2015, Annals of Human Genetics CrossRef
7. MCP-1-2518A>G Polymorphism and Myocardial Infarction Risk: A Meta-Analysis and Meta-Regression
   Bin Mao et al, 2013, Genetic Testing and Molecular Biomarkers CrossRef